Reviva Pharmaceuticals Holdings (RVPH) Prepaid Assets (2018 - 2026)
Reviva Pharmaceuticals Holdings (RVPH) posted Prepaid Assets of $549684.0 for Q1 2026, down 17.3% sequentially from $664685.0 in Q4 2025, and down 27.3% YoY from $756066.0 in Q1 2025.
Reviva Pharmaceuticals Holdings (RVPH) Prepaid Assets (2018 - 2026) Analysis & Trends
Reviva Pharmaceuticals Holdings has reported Prepaid Assets for 9 years, with the latest figure at $549684.0 in Q1 2026.
- Quarterly Prepaid Assets fell 27.3% year-over-year to $549684.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $549684.0 (down 27.3% YoY) and the FY2025 annual result came in at $664685.0, changed 0.26% from the prior year.
- Prepaid Assets declined to $549684.0 in Q1 2026 per RVPH's latest filing, from $664685.0 in the prior quarter.
- Over five years, Prepaid Assets peaked at $1.8 million in Q1 2022 and troughed at $247927.0 in Q3 2025.
- A 5-year average of $715057.2 and a median of $664685.0 in 2025 frame the typical range for Prepaid Assets.
- The widest YoY moves for Prepaid Assets: up 161.72% in 2024, down 54.84% in 2024.
- Over 5 years, Prepaid Assets stood at $403819.0 in 2022, then slumped by 36.94% to $254637.0 in 2023, then surged by 161.72% to $666435.0 in 2024, then retreated by 0.26% to $664685.0 in 2025, then fell by 17.3% to $549684.0 in 2026.
- According to Business Quant data, Prepaid Assets over the past three periods registered $549684.0, $664685.0, and $247927.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Reviva Pharmaceuticals Holdings | 6.74 Mn | 6.74 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 400,909.00 |
| Mar 31, 2026 | 549,684.00 |
| Dec 31, 2025 | 664,685.00 |
| Sep 30, 2025 | 247,927.00 |
| Jun 30, 2025 | 346,964.00 |
| Mar 31, 2025 | 756,066.00 |
| Dec 31, 2024 | 666,435.00 |
| Sep 30, 2024 | 325,808.00 |
| Jun 30, 2024 | 525,826.00 |
| Mar 31, 2024 | 743,381.00 |
| Dec 31, 2023 | 254,637.00 |
| Sep 30, 2023 | 414,743.00 |
| Jun 30, 2023 | 690,440.00 |
| Mar 31, 2023 | 1.65 Mn |
| Dec 31, 2022 | 403,819.00 |
| Sep 30, 2022 | 849,023.00 |
| Jun 30, 2022 | 1.22 Mn |
| Mar 31, 2022 | 1.85 Mn |
| Sep 30, 2021 | 402,316.00 |
| Jun 30, 2021 | 733,933.00 |